hotspot -WSS

hotspot

author：Wikipedia 2025-09-29 22:38:14 - browse：7471

BARCELONA, Spain — Some of the patients waiting in the oncology ward of a hospital here, with its green-tiled floor and white walls, had arrived for a newfangled remedy for blood cancers, what’s known as a CAR-T therapy.

The patients were not here for one of the brand-name medicines — a Kymriah or Yescarta — that have shown the power of these cell-based approaches and helped reap their makers hundreds of millions of dollars. Rather, they would be receiving a CAR-T brewed up right here at Hospital Clínic de Barcelona.

Under a special European policy, the CAR-T developed by the hospital’s experts had won regulatory approval in Spain and was reimbursed by the national health system like other authorized medications. The therapy provided another option for patients, all at a price of 89,000 euros ($97,000), roughly a third of the list prices of the CAR-T products from biopharma companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： CDC recommends RSV monoclonal antibody for infants

focus

WSS

Florida officials tell state schools to teach AP Psychology 'in its entirety'

John Green on his newest strategy for fighting tuberculosis

Late stage cancers on the rise after pandemic delayed screenings

Medicare coverage of Wegovy, once blocked, now looks possible

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

'Null' research findings aren't empty of meaning. Let's publish them

knowledge

hotspot

focus

Walensky prepares to leave CDC — and Congress — behind

Medicare coverage of Wegovy, once blocked, now looks possible

Activists slam private health insurers over coverage restrictions

Why depression after traumatic brain injury is distinct

In age of alternative facts, a scholarly course on calling out crap

How to save health care price transparency rules

Affirmative action in medical school literally saved lives

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

Hepatitis C has a cure — but many Americans still lack access to it

Heart disease in astronauts blamed on cosmic radiation

knowledge

Alnylam reports growth in sales of rare disease treatments

Boston's new lab space is opening empty

Personalized medicine goes far beyond genetics

When waiting feels immoral: Empathy in the emergency department

A controversial new treatment promises to make little people taller

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

explore

entertainment

focus

knowledge